Wei Liu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Tianjin Medical University Cancer Institute and Hospital, Leshan Normal University, National Clinical Research, Model Animal Research Center, Peking University Third Hospital, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0003-1129-0595

发表论文 52 篇 · 总被引 674 次 · h-index 14

代表论文

• Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System (2022 · ACS Applied Materials & Interfaces · 被引 63)
• Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel (2023 · Acta Pharmaceutica Sinica B · 被引 31)
• Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs (2022 · Journal of Nanobiotechnology · 被引 29)
• Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression (2021 · BMC Pulmonary Medicine · 被引 18)
• Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression (2025 · Cell Research · 被引 14)
• Predicting Secondary Vertebral Compression Fracture After Vertebral Augmentation via CT-Based Machine Learning Radiomics-Clinical Model (2024 · Academic Radiology · 被引 10)